RNAi screening identifies KAT8 as a key molecule important for cancer cell survival

Shuang Zhang1, Xianhong Liu, Yong Zhang

  • 1Department of Pathophysiology, Norman Bathune College of Medical Sciences, Jilin University, Changchun, China.

Insights

Histone acetyltransferases (HATs) are crucial in cancer. This study identifies KAT8 as a key regulator of lung cancer cell viability, suggesting it as a potential therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • Histone acetyltransferases (HATs) play vital roles in cancer by regulating gene expression, chromatin structure, and DNA repair.
  • Aberrant HAT expression is observed in various cancers, but their specific functions and mechanisms in cancer remain poorly understood.
  • Understanding HATs' roles is critical for developing novel cancer therapies.

Purpose of the Study:

  • To systematically investigate the function of HATs in lung cancer cell growth and viability using a large-scale RNAi screen.
  • To elucidate the molecular mechanisms by which specific HATs influence cancer progression.
  • To identify potential therapeutic targets within the HAT family for lung cancer treatment.

Main Methods:

  • Conducted a lentiviral vector-mediated RNA interference (RNAi) screen to assess the impact of HAT genes on A549 lung cancer cell viability.
  • Performed further experiments to validate the role of identified HATs, focusing on KAT8.
  • Utilized molecular assays to investigate signaling pathways, cell cycle regulation, and apoptosis-related gene expression.

Main Results:

  • Identified eight HAT genes that significantly affect A549 cell viability.
  • Demonstrated that KAT8 regulates G2/M cell cycle arrest via the AKT/ERK-cyclin D1 signaling pathway.
  • Showed that KAT8 inhibition induces p53 and reduces bcl-2 expression, indicating an impact on apoptosis.

Conclusions:

  • KAT8 plays a significant role in regulating lung cancer cell viability and progression.
  • The findings highlight KAT8 as a potential novel therapeutic target for cancer treatment.
  • Further research into KAT8-mediated pathways could lead to targeted cancer therapies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...